The store will not work correctly when cookies are disabled.
US9428478, TG6-199
ID: ALA3962738
PubChem CID: 71116233
Max Phase: Preclinical
Molecular Formula: C20H21N3O3
Molecular Weight: 351.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N2CCN(C(=O)c3cc4cc(O)ccc4[nH]3)CC2)cc1
Standard InChI: InChI=1S/C20H21N3O3/c1-26-17-5-2-15(3-6-17)22-8-10-23(11-9-22)20(25)19-13-14-12-16(24)4-7-18(14)21-19/h2-7,12-13,21,24H,8-11H2,1H3
Standard InChI Key: GNDNVGJPNUTBMV-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-3.9394 -13.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7395 -13.4959 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9798 -12.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4798 -12.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2768 -10.9139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4666 -9.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9666 -9.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7232 -10.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2883 -8.3139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7883 -8.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5428 -7.0227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7974 -5.7210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2973 -5.7159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4572 -7.0123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5497 -4.4224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7497 -4.4245 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
6 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
12 15 1 0
15 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
21 23 2 0
23 24 1 0
24 25 2 0
25 19 1 0
25 26 1 0
26 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.41 | Molecular Weight (Monoisotopic): 351.1583 | AlogP: 2.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 68.80 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.56 | CX Basic pKa: 3.99 | CX LogP: 2.57 | CX LogD: 2.56 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.76 | Np Likeness Score: -1.00 |
References
1. (2016) Piperazine derivatives, compositions, and uses related thereto, |